Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2008

01-11-2008 | Original Article

Predictors of Mortality in Patients with Stable COPD

Authors: Cristóbal Esteban, MD, José M. Quintana, MD, PhD, Myriam Aburto, MD, PhD, Javier Moraza, MD, Mikel Egurrola, MD, Pedro Pablo España, MD, Julio Pérez-Izquierdo, MD, Alberto Capelastegui, MD, PhD

Published in: Journal of General Internal Medicine | Issue 11/2008

Login to get access

Abstract

OBJECTIVES

To determine which easily available clinical factors are associated with mortality in patients with stable COPD and if health-related quality of life (HRQoL) provides additional information.

DESIGN

Five-year prospective cohort study.

SETTING

Five outpatient clinics of a teaching hospital.

PARTICIPANTS

Six hundred stable COPD patients recruited consecutively.

MEASUREMENTS

The variables were age, FEV1%, dyspnea, previous hospital admissions and emergency department visits for COPD, pack-years of smoking, comorbidities, body mass index, and HRQoL measured by Saint George’s Respiratory Questionnaire (SGRQ), Chronic Respiratory Questionnaire (CRQ), and Short-Form 36 (SF-36). Logistic and Cox regression models were used to assess the influence of these variables on mortality and survival.

RESULTS

FEV1%(OR: 0.62, 95% CI 0.5 to 0.75), dyspnea (OR 1.92, 95% CI 1.2 to 3), age (OR 2.41, 95% CI 1.6 to 3.6), previous hospitalization due to COPD exacerbations (OR 1.53, 1.2 to 2) and lifetime pack-years (OR 1.15, 95% CI 1.1 to 1.2) were independently related to respiratory mortality. Similarly, these factors were independently related to all-cause mortality with dyspnea having the strongest association (OR 1.54, 95% CI 1.1 to 2.2). HRQoL was an independent predictor of respiratory and all-cause mortality only when dyspnea was excluded from the models, except scores on the SGRQ were associated with all-cause mortality with dyspnea in the model.

CONCLUSIONS

Among patients with stable COPD, FEV1% was the main predictor of respiratory mortality and dyspnea of all-cause mortality. In general, HRQoL was not related to mortality when dyspnea was taken into account, and CRQ and SGRQ behaved in similar ways regarding mortality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163:1256–76.PubMed Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163:1256–76.PubMed
2.
go back to reference American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152(suppl):S77–120. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152(suppl):S77–120.
3.
go back to reference Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133:14–20.PubMed Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133:14–20.PubMed
4.
go back to reference Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15 year follow up study. Am Rev Respir Dis. 1979;119:895–902.PubMed Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15 year follow up study. Am Rev Respir Dis. 1979;119:895–902.PubMed
5.
go back to reference Nishimura K, Takateru I, Tsukino M, et al. Dyspnea is a better predictor of 5 year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–40.PubMedCrossRef Nishimura K, Takateru I, Tsukino M, et al. Dyspnea is a better predictor of 5 year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–40.PubMedCrossRef
6.
go back to reference Landbo C, Presscott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856–61.PubMed Landbo C, Presscott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856–61.PubMed
7.
go back to reference Soler-Cataluña JJ, Martinez-Garcia MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–31.PubMedCrossRef Soler-Cataluña JJ, Martinez-Garcia MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–31.PubMedCrossRef
8.
go back to reference Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167:544–9.PubMedCrossRef Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167:544–9.PubMedCrossRef
9.
go back to reference Cote CG, Celli BR. Predictors of mortality in chronic obstructive pulmonary disease. Clin Chest Med. 2007;28:515–24.PubMedCrossRef Cote CG, Celli BR. Predictors of mortality in chronic obstructive pulmonary disease. Clin Chest Med. 2007;28:515–24.PubMedCrossRef
10.
go back to reference Celli BC, Cote CG, Marín JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. NEJM. 2004;350:1005–12.PubMedCrossRef Celli BC, Cote CG, Marín JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. NEJM. 2004;350:1005–12.PubMedCrossRef
11.
go back to reference Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:680–5.PubMedCrossRef Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:680–5.PubMedCrossRef
12.
go back to reference Oga T, Nishimura K, Tsukino M, et al. Health status measured with the CRQ does not predict mortality in COPD. Eur Respir J. 2002;20:1147–51.PubMedCrossRef Oga T, Nishimura K, Tsukino M, et al. Health status measured with the CRQ does not predict mortality in COPD. Eur Respir J. 2002;20:1147–51.PubMedCrossRef
13.
go back to reference Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ. 1959;2:257–66.PubMedCrossRef Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ. 1959;2:257–66.PubMedCrossRef
14.
go back to reference Medical Section of the American Lung Association. Standardization of spirometry: 1994 update. Am Rev Respir Dis. 1994;152:1107–36. Medical Section of the American Lung Association. Standardization of spirometry: 1994 update. Am Rev Respir Dis. 1994;152:1107–36.
15.
go back to reference Sanchis J. Normativa para la espirometría forzada: Grupo de trabajo de la SEPAR para la práctica de la espirometría clínica. Arch Bronconeumol. 1989;25:132–42. Sanchis J. Normativa para la espirometría forzada: Grupo de trabajo de la SEPAR para la práctica de la espirometría clínica. Arch Bronconeumol. 1989;25:132–42.
16.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function test, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J. 1993;16:5–40. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function test, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J. 1993;16:5–40.
17.
go back to reference Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163:1256–76. (Updated 2006). Available at URL: www.goldcopd.com.PubMed Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163:1256–76. (Updated 2006). Available at URL: www.​goldcopd.​com.PubMed
18.
go back to reference Ware JE, Snow KK, Kosinsky M, et al. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute; 1993. Ware JE, Snow KK, Kosinsky M, et al. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute; 1993.
19.
go back to reference Alonso J, Prieto L, Ferrer M, et al. Testing the measurement properties of the Spanish version of the SF-36 health survey among male patients with chronic obstructive pulmonary disease. J Clin Epidemiol. 1998;51:1087–94.PubMedCrossRef Alonso J, Prieto L, Ferrer M, et al. Testing the measurement properties of the Spanish version of the SF-36 health survey among male patients with chronic obstructive pulmonary disease. J Clin Epidemiol. 1998;51:1087–94.PubMedCrossRef
20.
go back to reference Jones PW, Quirk FH, Baveystock CM. The St George’s respiratory questionnaire. Respir Med. 1991;85(Suppl B):25–31.PubMedCrossRef Jones PW, Quirk FH, Baveystock CM. The St George’s respiratory questionnaire. Respir Med. 1991;85(Suppl B):25–31.PubMedCrossRef
21.
go back to reference Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St George’s Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996;9:1160–6.PubMedCrossRef Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St George’s Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996;9:1160–6.PubMedCrossRef
22.
go back to reference Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–8.PubMed Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–8.PubMed
23.
go back to reference Güell R, Casan P, Sangenís M, et al. Quality of life in patient with chronic respiratory disease: the Spanish version of the chronic respiratory questionnaire (CRQ). Eur Respir J. 1998;11:55–60.PubMedCrossRef Güell R, Casan P, Sangenís M, et al. Quality of life in patient with chronic respiratory disease: the Spanish version of the chronic respiratory questionnaire (CRQ). Eur Respir J. 1998;11:55–60.PubMedCrossRef
24.
go back to reference Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441–8.PubMedCrossRef Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441–8.PubMedCrossRef
25.
go back to reference Anthonisen NR, Connett JE, Enright PL, et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166:333–9.PubMedCrossRef Anthonisen NR, Connett JE, Enright PL, et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166:333–9.PubMedCrossRef
26.
go back to reference Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 1996;154:959–7.PubMed Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 1996;154:959–7.PubMed
27.
go back to reference Hersh CP, DeMeo DL, Al-Ansari E, et al. Predictors of survival in severe, early onset COPD. Chest. 2004;126:1443–51.PubMedCrossRef Hersh CP, DeMeo DL, Al-Ansari E, et al. Predictors of survival in severe, early onset COPD. Chest. 2004;126:1443–51.PubMedCrossRef
28.
go back to reference Goel A, Pinckney RG, Littenberg B. APACHE II predicts long-term survival in COPD patients admitted to a general medical ward. J Gen Intern Med. 2003;18:824–30.PubMedCrossRef Goel A, Pinckney RG, Littenberg B. APACHE II predicts long-term survival in COPD patients admitted to a general medical ward. J Gen Intern Med. 2003;18:824–30.PubMedCrossRef
29.
go back to reference Mahler DA, Mejia-Alfaro R, Ward J, et al. Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness. J Appl Physiol. 2001;90:2188–96.PubMed Mahler DA, Mejia-Alfaro R, Ward J, et al. Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness. J Appl Physiol. 2001;90:2188–96.PubMed
30.
go back to reference Fletcher C. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by MRC committee on the aetiology of chronic bronchitis (MRC breathlessness score). BMJ. 1960;2:1665. Fletcher C. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by MRC committee on the aetiology of chronic bronchitis (MRC breathlessness score). BMJ. 1960;2:1665.
31.
go back to reference Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116:1632–37.PubMedCrossRef Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116:1632–37.PubMedCrossRef
32.
go back to reference Hajiro T, Nishimura K, Tsukino M, et al. Comparison of discriminative properties among disease specific questionnaires for measuring health related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:785–90.PubMed Hajiro T, Nishimura K, Tsukino M, et al. Comparison of discriminative properties among disease specific questionnaires for measuring health related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:785–90.PubMed
33.
go back to reference Hajiro T, Nishimura K, Tsukino M, et al. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med. 2000;94:841–46.PubMedCrossRef Hajiro T, Nishimura K, Tsukino M, et al. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med. 2000;94:841–46.PubMedCrossRef
Metadata
Title
Predictors of Mortality in Patients with Stable COPD
Authors
Cristóbal Esteban, MD
José M. Quintana, MD, PhD
Myriam Aburto, MD, PhD
Javier Moraza, MD
Mikel Egurrola, MD
Pedro Pablo España, MD
Julio Pérez-Izquierdo, MD
Alberto Capelastegui, MD, PhD
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 11/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-008-0783-x

Other articles of this Issue 11/2008

Journal of General Internal Medicine 11/2008 Go to the issue

Letter to Editor

Salt and Mortality